These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3019734)

  • 1. (+)-3-PPP antagonizes the discriminative stimulus effects of (+)-N-allylnormetazocine.
    Balster RL
    Eur J Pharmacol; 1986 Aug; 127(3):283-6. PubMed ID: 3019734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L; Wong EH; Kesingland AC; Tricklebank MD
    Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] but not (-)-3-PPP produces (+)-N-allylnormetazocine-like (SKF 10,047) discriminative stimuli.
    Steinfels GF; Tam SW; Cook L
    Life Sci; 1986 Dec; 39(26):2611-5. PubMed ID: 3796207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of a sigma receptor agonist in the rat: role of monoamine systems.
    Steinfels GF; Tam SW; Cook L
    Eur J Pharmacol; 1987 Sep; 141(1):163-6. PubMed ID: 2822445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys.
    Holtzman SG
    Pharmacol Biochem Behav; 1993 Feb; 44(2):349-55. PubMed ID: 8446667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.
    Steinfels GF; Tam SW; Cook L
    Psychopharmacology (Berl); 1987; 91(1):5-9. PubMed ID: 3029793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine.
    Tricklebank MD; Singh L; Oles RJ; Wong EH; Iversen SD
    Eur J Pharmacol; 1987 Sep; 141(3):497-501. PubMed ID: 2822452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
    Balster RL
    J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs.
    Glennon RA; Young R; Herndon JL
    Pharmacol Biochem Behav; 1993 Aug; 45(4):865-9. PubMed ID: 8105490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
    Slifer BL; Dykstra LA
    Life Sci; 1987 Jan; 40(4):343-9. PubMed ID: 3027481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats.
    Shannon HE
    Eur J Pharmacol; 1982 Oct; 84(3-4):225-8. PubMed ID: 7173321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the discriminative stimulus effect of an enkephalin analog, EK-399, in the rat].
    Nishida N; Yasuhara Y; Chiba S
    Nihon Yakurigaku Zasshi; 1991 Jun; 97(6):361-9. PubMed ID: 1651892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT; Herz A
    Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sigma receptor ligands on schedule-controlled behavior of rats: relation to sigma and PCP receptor binding affinity.
    Wettstein JG; Roman FJ; Rocher MN; Junien JL
    Psychopharmacology (Berl); 1991; 104(2):157-63. PubMed ID: 1652142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
    J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y; Hiller JM; Simon EJ
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline.
    Holtzman SG; Steinfels GF
    Psychopharmacology (Berl); 1994 Nov; 116(3):243-8. PubMed ID: 7892412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a multi-site model of the rat brain sigma receptor.
    Bowen WD; Hellewell SB; McGarry KA
    Eur J Pharmacol; 1989 Apr; 163(2-3):309-18. PubMed ID: 2542066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes.
    Itzhak Y; Stein I; Zhang SH; Kassim CO; Cristante D
    J Pharmacol Exp Ther; 1991 Apr; 257(1):141-8. PubMed ID: 1850463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.